CCL19 Protein (AA 22-98)
Our Local Distributor
北京 101111
Quick Overview for CCL19 Protein (AA 22-98) (ABIN6952156)
抗原
See all CCL19 蛋白蛋白类型
生物活性
宿主
资源
应用范围
纯度
-
-
产品特性
- AA 22-98
-
序列
- GTNDAEDCCL SVTQKPIPGY IVRNFHYLLI KDGCRVPAVV FTTLRGRQLC APPDQPWVER IIQRLQRTSA KMKRRSS
-
产品特性
- Recombinant Human CCL19 (MIP-3beta)
-
内毒素水平
- <0.01 EU per 1μg of the protein by the LAL method
-
Biological Activity Comment
- EC50 = 7.0 nM determined by Migration Assay with recombinant human CCR7
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Spin tube prior to resuspending. Recommended at 100 μg/mL in sterile water
-
储存条件
- -20 °C,-80 °C
-
储存方法
-
12 months from date of receipt, -20 to -70 °C as supplied.
Suggest to use immediately after reconstitution
1 month at -20 to -70 °C under sterile conditions after reconstitution. -
有效期
- 12 months
-
-
- CCL19 (Chemokine (C-C Motif) Ligand 19 (CCL19))
-
别名
- CCL19 (MIP-3beta)
-
背景
- Macrophage inflammatory protein-3-beta (MIP-3beta/CCL19), also known as EBI1 ligand chemokine (ELC), directs chemotaxis of dendritic cells, and certain B- and T- lymphocytes, but not monocytes or granulocytes. It is constituitively expressed in thymus and lymph nodes and binds specifically to target cells expressing the receptor CCR7. Being a homeostatic chemokine, its primary physiological role is considered to be in the normal recirculation and homing of lymphocyte. However, MIP-3beta could also be proinflammatory, and is implicated in the post-HIV infection responses.
-
分子量
- 8.800 kDa
-
UniProt
- Q99731
-
途径
- Positive Regulation of Immune Effector Process
抗原
-